Retatrutide Peptide: What the Research Actually Shows in 2026

Retatrutide gets talked about like it’s already available, but it isn’t — and that gap between hype and reality is where most of the confusion (and risk) comes from. It’s a real drug, developed by Eli Lilly, currently working through Phase 3 clinical trials, with results so far that have genuinely surprised obesity researchers. It’s … Read more